|
Jun 9
|
Regeneron and Sanofi’s dupilumab shows promise in AD trial
|
|
Jun 9
|
Sanofi Appoints James Guy as Country Lead, Canada and General Manager, Specialty Care
|
|
Jun 9
|
Press Release: Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV season
|
|
Jun 6
|
Challenges pharma companies face in push into US manufacturing
|
|
Jun 6
|
Sanofi (SNY) Stock Down 5% Despite AERIFY-1 Success
|
|
Jun 5
|
Press release: Sanofi Launches 2025 Global Employee Stock Purchase Plan
|
|
Jun 4
|
MLTX Stock Gains 18% as Merck Reportedly Eyes Buyout
|
|
May 23
|
Pharma Stock Roundup: NVO CEO Resigns, SNY to Buy VIGL & More
|
|
May 22
|
Vigil Neuroscience to be acquired by Sanofi for $8.00 per share
|
|
May 22
|
Sanofi opens new, $130 million NJ offices in Morristown, showcasing innovative, modern design and strengthening US presence
|
|
May 22
|
Sanofi buys Vigil Neuroscience for $470m in Alzheimer’s push
|
|
May 22
|
European Equities Close Lower in Thursday Trading; Eurozone Business Activity Swings to Contraction
|
|
May 22
|
Vigil Neuroscience Stock Triples as Drugmaker Agrees to Acquisition by Sanofi
|
|
May 22
|
MRNA Stock Down on Withdrawal of FDA Filing for COVID-Flu Combo Shot
|
|
May 22
|
Sanofi to Join Alzheimer's Space With Vigil Neuroscience Buyout
|
|
May 22
|
Sanofi Inks A $470 Million Alzheimer's Deal, Sending This Dollar Stock Flying
|
|
May 22
|
Sanofi gains experimental Alzheimer’s drug through Vigil buyout
|
|
May 22
|
Sanofi Boosts Alzheimer's Pipeline With Vigil Neuroscience Acquisition
|
|
May 22
|
Sanofi Set to Acquire Vigil Neuroscience in $470 Million Deal
|
|
May 22
|
Sanofi to acquire Vigil Neuroscience in Alzheimer’s drug play
|